PHARMA NORD EXPORT ApS: Financial statements 2014
CVR: 70996510
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,928,662 and a net result of DKK 3,143,964 compared with DKK 6,252,296 the year before. That is a decrease of 15.1% compared with the year before. Equity in the 2014 report amounted to DKK 56,118,887. The solvency ratio was 74.9%.
- Gross Profit
- DKK 1,928,662
- Profit/Loss
- DKK 3,143,964
- Equity
- DKK 56,118,887
- Total Assets
- DKK 74,933,220
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1.9 mio. | 3.1 mio. | 56.1 mio. | - |
| 2013 | - | 2.3 mio. | 6.3 mio. | 53 mio. | - |
| 2012 | - | 2.3 mio. | 6 mio. | 47.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMA NORD EXPORT ApS has published its annual report for 2013. Gross profit came to DKK 2,270,438, and the net result was DKK 6,252,296.
As of February 12, 2014, Bent Henriksen has left the board of directors of PHARMA NORD EXPORT ApS.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.